Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;12(1):40-45.
doi: 10.1016/j.prnil.2023.12.001. Epub 2023 Dec 13.

High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group

Ee Jean Lim  1 , Daniele Castellani  2 , Bhaskar K Somani  3 , Mehmet I Gökce  4 , Khi Yung Fong  5 , Fernando G Sancha  6 , Thomas R W Herrmann  7 , Sarvajit Biligere  8 , Azimdjon N Tursunkulov  9 , Marco Dellabella  10 , Mario Sofer  11 , Dmitry Enikeev  12 , Vladislav Petov  12 , Nariman Gadzhiev  13 , Dean Elterman  14 , Abhay Mahajan  15 , Moises R Socarras  6 , Dilmurod S Yunusov  9 , Furkat Nasirov  16 , Jeremy Y C Teoh  17 , Vineet Gauhar  8
Affiliations

High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group

Ee Jean Lim et al. Prostate Int. 2024 Mar.

Abstract

Background: Endoscopic enucleation of the prostate (EEP) has gained acceptance as an equitable alternative to transurethral resection of the prostate for benign prostate hyperplasia (BPH). Our primary aim is to compare peri-operative outcomes of EEP using thulium fiber laser (TFL) against high-power holmium laser (HPHL) in hands of experienced surgeons for large prostates (≥80 ml in volume). Secondary outcomes were assess complications within 1 year of follow up.

Materials and methods: We retrospectively reviewed patients with benign prostatic hyperplasia who underwent EEP with TFL or HPHL in 13 centers (January 2019-January 2023). Patients with prostate volume ≥80 ml were included, while those with concomitant prostate cancer, previous prostate/urethral surgery, and pelvic radiotherapy were excluded.

Results: Of 1,929 included patients, HPHL was utilized in 1,459 and TFL in 470. After propensity score matching (PSM) for baseline characteristics, 247 patients from each group were analyzed. Overall operative time (90 [70, 120] vs. 52.5 [39, 93] min, P < 0.001) and enucleation time (90 [70, 105] vs. 38 [25, 70] min, P < 0.001) were longer in the TFL group, with comparable morcellation time (13 [10, 19.5] vs. 13 [10, 16.5] min, P = 0.914). In terms of postoperative outcomes, there were no differences in 30-day complications such as acute urinary retention, urinary tract infection or sepsis. In the PSM cohort, univariable analyses showed that higher age, lower preoperative Qmax, higher preoperative PVRU, and longer operation time were associated with higher odds of postoperative incontinence, while 2-lobe enucleation had lower odds of incontinence compared to 3-lobe enucleation.

Conclusions: This real-world study reaffirms that HPHL and TFL in large prostates are equally efficacious in terms of 30-day complications. TFL with the en-bloc technique has a shorter operative time which significantly improves short- and medium-term functional outcomes.

Keywords: Endoscopic enucleation of the prostate; Laser therapy; Postoperative complications; Prostatic hyperplasia; Urinary incontinence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Gudaru K., Gonzalez Padilla D.A., Castellani D., Tortolero Blanco L., Tanidir Y., Ka Lun L., et al. A global knowledge, attitudes and practices survey on anatomical endoscopic enucleation of prostate for benign prostatic hyperplasia among urologists. Andrologia. 2020 Sep;52(8) - PubMed
    1. Riveros C., Di Valerio E., Bacchus M., Chalfant V., Leelani N., Thomas D., et al. Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate. Prostate Int. 2023 Mar 1;11(1):20–26. - PMC - PubMed
    1. Tricard T., Xia S., Xiao D., Tong Z., Gaillard V., Sun J. Outcomes of holmium laser enucleation of the prostate (HoLEP) for very large-sized benign prostatic hyperplasia (over 150 mL): open simple prostatectomy is dead. World J Urol. 2023 Aug;41(8):2249–2253. - PubMed
    1. Lee M.S., Assmus M.A., Ganesh M., Han J., Helon J., Mai Q., et al. An outcomes comparison between holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy for large gland benign prostatic hypertrophy. Urology. 2023 Mar;173:180–186. - PubMed
    1. Van der Jeugt J., Umari P., Mottaran A., Ribeiro L., Lambert E., Vollemaere J., et al. Holmium laser enucleation of the prostate vs robot-assisted simple prostatectomy for lower urinary tract symptoms in patients with extremely large prostates ≥200 cc: a comparative analysis. J Endourol. 2023 Aug;37(8):895–902. - PubMed